EIR Ascent Pharmaceuticals Nov 2018

Karen Kosar FDA$595.00 - Available Now

FDA investigators audited the Ascent Pharmaceuticals - Central Islip, NY, United States facility and issued inspectional observation (via FDA 483) on 07 Nov 2018.

Product details

  • Category:
  • Inspection end: 07 Nov 2018
  • Location: Central Islip, United States
  • FEI: 3009518416
Add To Cart